Deazaneplanocin A Is a Promising Drug to Kill Multiple Myeloma Cells in Their NicheJérémie Rouger(Normandie Université), Brigitte Sola(Inserm)PLoS ONESeptember 25, 201410.1371/journal.pone.0107009Cited by 10SaveCiteExport RISWatch citationsRelated PapersSenescence-associated secretory phenotype favors the emergence of cancer stem-like cells|Cell Death and Disease|2012|158Relevance of cyclin D1b expression and CCND1polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma|BMC Cancer|2006|32ROS Overproduction Sensitises Myeloma Cells to Bortezomib-Induced Apoptosis and Alleviates Tumour Microenvironment-Mediated Cell Resistance|Cells|2020|24XPO1E571K Mutation Modifies Exportin 1 Localisation and Interactome in B-Cell Lymphoma|Cancers|2020|22